Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25862,909,1.21 [1.05-1.40],0.0094071954032026
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25892,145,1.47 [1.06-2.04],0.0215225560901101
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27494,156,1.41 [1.02-1.96],0.0364083089834206
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20559,504,1.55 [1.31-1.85],6.362609770967553e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27431,93,1.11 [0.71-1.75],0.6482408570413829
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26706,77,2.01 [1.35-2.99],0.0005766627812554
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28486,92,1.12 [0.71-1.75],0.6301767823741
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28506,64,0.93 [0.53-1.64],0.7995369753147006
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26141,46,1.60 [0.90-2.85],0.111186138437737
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27954,107,1.64 [1.14-2.35],0.0075485325823275
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27913,66,1.91 [1.24-2.93],0.0031374814025561
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28550,66,0.65 [0.36-1.18],0.1570910492334339
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28505,101,1.28 [0.85-1.94],0.2366242188510066
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28495,91,1.27 [0.82-1.96],0.2864572507781896
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,28309,45,1.01 [0.52-1.96],0.970520543582622
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27654,395,1.10 [0.89-1.37],0.3863856166660261
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27406,147,1.12 [0.78-1.59],0.5425448346164301
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27513,254,1.13 [0.87-1.48],0.3590860412109766
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24783,29,1.61 [0.79-3.27],0.1871445815416735
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24803,49,nan [nan-nan],
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24882,128,0.80 [0.53-1.20],0.2799624611467013
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24887,133,0.83 [0.55-1.24],0.3536178145689304
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13917,294,1.24 [0.96-1.59],0.0930727290616708
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11159,28,1.15 [0.53-2.52],0.7212303642779205
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24802,48,1.14 [0.61-2.11],0.6898654154024385
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26379,832,1.23 [1.06-1.43],0.0076627222843671
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27464,201,1.03 [0.76-1.40],0.8581064947933502
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28122,78,1.13 [0.70-1.82],0.6124074773367268
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28619,73,1.23 [0.77-1.97],0.3946031896949495
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,28379,49,0.81 [0.42-1.55],0.5198005225310296
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28627,39,0.69 [0.32-1.49],0.3457765596302309
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Stomach,28668,32,0.47 [0.20-1.16],0.1006825647094632
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,28352,302,1.34 [1.06-1.69],0.0149764040326122
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28597,118,1.28 [0.87-1.87],0.2063956326555673
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28602,97,1.47 [0.99-2.19],0.0544772617675172
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28567,47,1.60 [0.92-2.80],0.0965003810751018
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",28569,47,1.61 [0.92-2.80],0.0964536993066602
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,28460,251,0.81 [0.60-1.08],0.1543600667782247
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28628,111,0.65 [0.41-1.02],0.0624287697076382
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,28537,193,1.39 [1.04-1.85],0.0241990006885714
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of breast,15805,94,0.96 [0.60-1.53],0.8586775590481087
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Leiomyoma of uterus,15432,703,1.00 [0.84-1.19],0.9933674139500422
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27626,202,1.24 [0.92-1.67],0.1529844384866132
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27509,360,1.06 [0.84-1.33],0.6484749739713029
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27509,360,1.06 [0.84-1.33],0.6484749739713029
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26269,367,1.35 [1.09-1.68],0.0062758831596577
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28184,80,1.37 [0.87-2.16],0.1697913158208561
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28397,107,1.11 [0.74-1.68],0.6018644045962351
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,25143,719,1.41 [1.21-1.65],1.0329911993102852e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27324,448,1.02 [0.83-1.26],0.8584642385002037
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26806,116,2.33 [1.72-3.16],6.122986118310328e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27891,56,2.01 [1.31-3.09],0.0014085666695742
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26791,101,2.23 [1.60-3.10],2.3854083826492183e-06
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,27028,338,1.91 [1.55-2.34],5.503650170979004e-10
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27018,328,1.89 [1.54-2.32],1.5330557164922803e-09
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26670,187,1.22 [0.89-1.68],0.2229642879598159
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26674,184,1.22 [0.88-1.68],0.2334985338073303
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24975,551,1.35 [1.13-1.61],0.0009766233893808
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24499,75,1.72 [1.14-2.60],0.0102088607376063
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24930,506,1.23 [1.02-1.49],0.030416397476248
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24468,44,1.22 [0.64-2.34],0.5432182380043945
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24504,80,1.83 [1.23-2.74],0.0031271995885991
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,24879,784,1.05 [0.89-1.23],0.5690459677856916
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24394,299,1.63 [1.30-2.05],2.844070280970264e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28220,230,1.71 [1.34-2.19],2.014563493937855e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28292,164,1.66 [1.23-2.22],0.0008139334189088
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26639,84,2.37 [1.65-3.41],2.7933032080890467e-06
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28549,84,2.18 [1.53-3.10],1.4990753784478695e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",24179,84,2.39 [1.65-3.44],3.1876475534707976e-06
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Alcohol dependence,26653,98,2.18 [1.53-3.10],1.4234662378178368e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,26618,68,1.55 [0.96-2.49],0.0731426907873349
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",24169,74,1.02 [0.60-1.72],0.94553404142134
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24497,402,0.98 [0.78-1.22],0.8408783010761065
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Depression,26896,349,0.91 [0.72-1.16],0.4463339578511829
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Depression or dysthymia,24342,306,0.97 [0.75-1.26],0.840351709065265
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24243,148,0.93 [0.64-1.35],0.7088315408477739
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Other anxiety disorders,27129,71,1.17 [0.72-1.91],0.5152543038991726
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,25491,1483,1.13 [1.01-1.27],0.0390239594887258
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23769,165,0.76 [0.53-1.11],0.1557491708915816
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28460,133,0.68 [0.45-1.03],0.0691744670480336
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27282,503,1.29 [1.07-1.54],0.0068837673330359
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,26951,172,1.48 [1.10-1.99],0.0095920243324357
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,26884,105,0.60 [0.38-0.97],0.0385156818437138
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28289,95,0.59 [0.36-0.97],0.0371120927784335
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,28164,41,1.32 [0.72-2.42],0.361467871208959
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,26956,177,1.50 [1.13-1.98],0.0049476210281158
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,28034,138,1.55 [1.14-2.11],0.0051176955147651
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27509,634,1.05 [0.88-1.25],0.5928510357635912
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",27017,142,0.93 [0.64-1.35],0.6998620425665354
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27215,340,1.16 [0.92-1.46],0.2085722099831963
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28444,87,1.01 [0.63-1.63],0.950850196374861
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,28413,56,0.93 [0.51-1.70],0.8060667591669007
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,28226,127,1.10 [0.75-1.61],0.6376334619007886
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28188,315,0.97 [0.76-1.25],0.8257828281317919
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,28045,172,1.01 [0.72-1.41],0.953000868442902
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27964,91,1.05 [0.66-1.67],0.8237507549048217
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27979,106,1.02 [0.67-1.57],0.9159912051931892
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27922,49,0.93 [0.49-1.78],0.8344465861240413
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26919,67,1.91 [1.28-2.86],0.0015183402026552
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27042,190,1.56 [1.19-2.05],0.0013072588185821
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28040,133,1.16 [0.80-1.68],0.4254551357241158
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28413,24,2.21 [1.15-4.28],0.0178740672411118
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1805,24,1.61 [0.79-3.27],0.1878818097761271
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26632,24,2.34 [1.22-4.49],0.0105821818482516
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28285,51,1.23 [0.69-2.18],0.4860620714216213
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28263,29,1.18 [0.54-2.55],0.6823837012636376
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28187,96,0.81 [0.50-1.30],0.3814050697427721
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28244,101,1.00 [0.65-1.56],0.9891146032037416
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,28540,127,0.58 [0.38-0.89],0.0130556992352909
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,28128,91,0.94 [0.59-1.50],0.7928665429627162
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22426,2014,1.37 [1.24-1.52],1.0730120668200552e-09
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28334,39,2.07 [1.22-3.52],0.0066951749909177
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23511,1335,1.28 [1.13-1.45],8.297494800208429e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,23536,1360,1.28 [1.14-1.45],6.172419486414126e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,22227,51,2.05 [1.28-3.27],0.002837178211587
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27118,581,1.26 [1.06-1.49],0.0077095090595566
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,26895,358,1.18 [0.95-1.46],0.1465510182780723
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27936,143,1.09 [0.77-1.55],0.6148328246835524
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28061,268,1.14 [0.88-1.46],0.3225164156560167
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28557,61,1.22 [0.74-2.03],0.4336186659536962
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26702,165,1.14 [0.83-1.58],0.4192561870649679
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26959,433,1.24 [1.02-1.50],0.0335864230855383
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28139,84,1.65 [1.11-2.45],0.0138114728726782
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28128,182,1.38 [1.03-1.84],0.0295039108657059
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,28118,63,2.19 [1.47-3.26],0.0001082126260747
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,28119,64,2.17 [1.46-3.23],0.000120547857677
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22237,61,2.28 [1.51-3.42],7.698472259282342e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25958,47,1.69 [1.01-2.85],0.0466184554274737
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,25987,76,0.89 [0.52-1.50],0.649451743607727
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19580,97,1.75 [1.21-2.55],0.0033234020362559
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19677,194,2.13 [1.65-2.73],3.719229156147159e-09
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25953,42,1.55 [0.86-2.79],0.1460262375692547
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25974,63,1.78 [1.14-2.78],0.0106945518193883
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28147,122,1.75 [1.28-2.39],0.0004821989644902
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28118,117,0.94 [0.62-1.42],0.7699209843612138
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28152,87,0.94 [0.58-1.51],0.7910593094079256
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28199,76,0.96 [0.58-1.60],0.8824240868466298
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27915,53,0.97 [0.53-1.78],0.9215171697982674
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27946,84,1.43 [0.94-2.17],0.0939570261707286
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27401,120,1.20 [0.82-1.76],0.3436713163240514
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27380,99,1.28 [0.85-1.92],0.2369734419234489
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28497,94,1.25 [0.82-1.89],0.296325433200566
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,27728,447,0.86 [0.69-1.07],0.1675959316977481
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,27911,56,1.71 [1.04-2.81],0.0345964070055719
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,24254,1990,1.11 [1.00-1.23],0.0440994261448713
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28441,142,0.78 [0.52-1.15],0.2031540374067033
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27428,189,1.65 [1.26-2.16],0.0003201583774555
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27399,160,1.83 [1.38-2.42],2.892736902454512e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28039,218,1.21 [0.91-1.60],0.1813851250799488
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28037,216,1.23 [0.93-1.62],0.1553308670758624
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27762,682,0.92 [0.78-1.10],0.3781787976530146
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,27179,99,0.91 [0.58-1.44],0.691459009585059
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,27191,111,1.23 [0.83-1.83],0.2987896251274415
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27521,441,0.91 [0.74-1.13],0.4142722801619131
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,27318,238,1.14 [0.86-1.50],0.3679521827628589
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16505,50,0.81 [0.41-1.59],0.5370050273720192
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26230,898,1.12 [0.97-1.30],0.1254726146648088
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,27933,110,1.66 [1.18-2.32],0.0032339463669315
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27933,110,1.66 [1.18-2.32],0.0032339463669315
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27933,110,1.66 [1.18-2.32],0.0032339463669315
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26847,816,1.09 [0.93-1.27],0.2887344384280058
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Asthma,21938,816,1.12 [0.96-1.31],0.1519492188965162
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21790,816,1.13 [0.97-1.32],0.1286656135298959
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21922,800,1.13 [0.96-1.32],0.1402019840080496
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28472,57,1.45 [0.87-2.42],0.1551892564721445
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,27310,43,1.32 [0.71-2.44],0.3766462320070882
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",28535,43,1.33 [0.72-2.46],0.3567795169131298
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27303,36,1.62 [0.87-3.01],0.1270835443296719
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,27279,78,1.54 [1.00-2.38],0.0485670720283717
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,27384,183,1.67 [1.27-2.20],0.0002363165925775
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27799,86,2.00 [1.39-2.87],0.0001818146648788
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20277,5247,1.00 [0.93-1.07],0.9355962482707108
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",28041,503,1.23 [1.02-1.49],0.0306667234546648
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28595,143,1.21 [0.85-1.74],0.2899048311990805
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,28601,133,1.13 [0.78-1.65],0.5192277388500602
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,27663,125,1.15 [0.78-1.68],0.4800525177344164
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27646,108,1.49 [1.02-2.17],0.0393260257516159
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28580,159,1.17 [0.83-1.65],0.3727198231843883
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27633,95,1.21 [0.78-1.87],0.3938173346999097
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27371,66,0.94 [0.54-1.64],0.8335252967320468
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28540,46,0.78 [0.39-1.55],0.4811304532959974
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,23058,207,0.76 [0.55-1.06],0.102029106332707
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24622,1771,0.88 [0.79-0.99],0.0320073738038494
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,23126,275,0.88 [0.67-1.16],0.3664530827768273
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23412,561,0.76 [0.62-0.93],0.0070484738961958
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22917,66,1.56 [0.97-2.49],0.0644420426978176
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22983,132,0.94 [0.63-1.39],0.7518885451813666
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22883,32,1.11 [0.52-2.39],0.7856084148482567
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,22955,104,0.83 [0.52-1.30],0.4127054839745755
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,22956,105,0.68 [0.43-1.08],0.1037571794761709
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28562,74,0.59 [0.34-1.03],0.0617992746062858
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,22955,104,0.73 [0.46-1.16],0.1769785709331317
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23501,650,0.92 [0.77-1.10],0.3712502674495997
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,28473,165,0.79 [0.55-1.13],0.1965246610828747
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,23241,390,0.83 [0.65-1.05],0.1215387354537962
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22967,116,1.01 [0.67-1.53],0.9626096486977036
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28465,192,1.15 [0.85-1.56],0.3730385381275966
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,28436,128,0.85 [0.57-1.28],0.4486224686129633
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,25835,1203,0.93 [0.82-1.06],0.2845885788620428
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,25037,405,0.96 [0.77-1.21],0.7443384867837441
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,24755,123,1.23 [0.86-1.78],0.2600917926088673
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,24728,96,1.68 [1.16-2.43],0.0059048263954128
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25244,612,0.73 [0.60-0.88],0.0012088385981462
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27760,760,1.16 [0.99-1.35],0.0693515422106496
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,23598,1705,1.08 [0.97-1.21],0.1426568907240223
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28326,75,1.74 [1.14-2.64],0.010173337517395
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",28582,106,1.75 [1.23-2.49],0.0017604558876485
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,27106,106,1.77 [1.24-2.52],0.0016412894364131
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,27081,81,1.74 [1.16-2.62],0.0078454509592553
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",28528,133,1.50 [1.08-2.10],0.0171523269071268
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,27133,133,1.51 [1.08-2.12],0.0159562157250587
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",27115,115,1.58 [1.11-2.26],0.0111933491977635
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27604,604,1.07 [0.89-1.28],0.4628749036319881
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27599,599,1.08 [0.90-1.29],0.4241319356995263
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21965,72,1.33 [0.83-2.13],0.241457743051903
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal stricture,28320,72,1.33 [0.83-2.13],0.2374564221451497
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21942,49,1.59 [0.93-2.71],0.0908181106657573
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22203,310,1.00 [0.78-1.28],0.988009099603772
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22075,182,0.95 [0.68-1.33],0.7857752032931613
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22151,258,1.26 [0.97-1.64],0.0781555740479719
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,27461,231,1.26 [0.96-1.66],0.0996456791752492
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28235,84,1.00 [0.62-1.60],0.9858039082216996
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,22074,181,1.06 [0.77-1.47],0.7194236724345927
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21983,90,1.11 [0.71-1.74],0.6436595498965161
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22695,802,1.08 [0.93-1.26],0.3234558259078446
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,22079,186,1.49 [1.12-1.98],0.0057811713741016
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28222,71,0.83 [0.48-1.43],0.5021480822233928
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,27909,124,3.80 [2.99-4.82],7.0189419253365565e-28
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,27850,65,3.49 [2.53-4.80],1.830209539063628e-14
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27393,539,1.05 [0.87-1.27],0.5876450479618273
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,27278,424,0.92 [0.74-1.14],0.437517420695432
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,26935,81,1.46 [0.96-2.23],0.0802845906332985
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26901,47,1.16 [0.62-2.17],0.6416317183121483
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,26917,63,1.62 [1.03-2.56],0.037764470588701
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),28491,63,1.64 [1.04-2.57],0.0331766410070399
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27372,289,1.20 [0.94-1.54],0.1424548462050466
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,27151,68,0.57 [0.32-1.03],0.0638984863947456
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,27136,53,0.52 [0.27-1.03],0.0604142466634148
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",27125,42,1.34 [0.72-2.50],0.3567715327625173
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27269,186,1.47 [1.10-1.96],0.0085077929200997
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,27264,181,1.51 [1.13-2.01],0.0055351014618071
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25994,1520,1.11 [0.99-1.25],0.0701582509833934
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28273,103,1.60 [1.10-2.31],0.0131272075225914
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,28222,477,0.99 [0.81-1.22],0.9363627275107372
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27533,544,1.04 [0.86-1.26],0.6883005251097694
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27859,402,1.06 [0.86-1.32],0.5724379765202021
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27564,107,0.83 [0.53-1.30],0.4207020633974107
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27685,228,1.14 [0.87-1.51],0.3436948967868748
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28401,88,1.53 [1.02-2.29],0.0379328033000744
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28385,72,1.77 [1.17-2.68],0.0070302997707532
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28365,52,2.29 [1.48-3.54],0.0001831965645378
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28489,35,1.11 [0.53-2.29],0.7849615645072276
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28486,32,1.11 [0.52-2.38],0.785561140483058
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27809,64,0.83 [0.47-1.47],0.5194341995230559
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,28110,365,1.01 [0.80-1.28],0.9060867666718287
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,27062,73,1.07 [0.64-1.78],0.8083357051526664
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,27091,102,1.07 [0.69-1.65],0.7754810273132309
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,27075,86,1.06 [0.66-1.71],0.8052283583167755
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",27205,216,1.04 [0.77-1.40],0.80709410681591
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,27178,189,1.09 [0.79-1.49],0.6107551218073917
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22175,3591,0.95 [0.87-1.03],0.1913759857762231
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23827,1898,1.01 [0.91-1.12],0.8931644785285031
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26169,1134,0.96 [0.84-1.10],0.5930585310575723
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22048,119,0.57 [0.36-0.90],0.0145955095554685
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22274,345,0.84 [0.66-1.08],0.1687461904280424
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28321,113,0.59 [0.37-0.93],0.0232034730371305
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28338,101,0.63 [0.39-1.02],0.05793637488924
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,22601,672,0.92 [0.77-1.10],0.3497938463031561
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",25255,672,0.92 [0.78-1.10],0.3720276787646386
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21975,46,1.79 [1.08-2.94],0.0225606148568374
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28264,45,1.94 [1.20-3.13],0.006870227965919
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22084,155,0.74 [0.51-1.08],0.1210474281305366
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21954,25,1.06 [0.45-2.49],0.8973126345394368
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22055,126,0.93 [0.62-1.38],0.7204620184752497
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28550,61,0.91 [0.52-1.61],0.7567213944808046
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22263,334,0.93 [0.73-1.19],0.5767157111113205
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22160,231,0.81 [0.60-1.09],0.1641437227875319
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23193,1264,1.10 [0.97-1.24],0.1532788459482559
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21967,38,1.07 [0.53-2.16],0.8563127618895517
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22106,177,0.83 [0.58-1.18],0.2900469154374951
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21964,35,0.97 [0.46-2.06],0.9386383259675476
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21960,31,0.70 [0.30-1.65],0.4120287969399655
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22464,535,1.23 [1.02-1.47],0.0281887254752735
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22374,445,1.28 [1.05-1.55],0.0155040839908099
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22693,287,0.94 [0.72-1.23],0.6438085811356511
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,28258,152,0.53 [0.35-0.79],0.0017525970102514
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,28147,41,0.63 [0.30-1.34],0.2275151454591156
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25627,49,1.36 [0.77-2.41],0.2939090736783586
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25801,223,0.89 [0.66-1.21],0.4625749227314644
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26503,925,0.89 [0.77-1.04],0.1445469288028361
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25717,139,0.74 [0.50-1.10],0.133482463551631
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25635,57,0.93 [0.52-1.69],0.8195864614644585
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26357,779,0.90 [0.76-1.06],0.1927692994206677
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25637,59,1.04 [0.60-1.82],0.8868217140850152
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25837,259,0.97 [0.73-1.28],0.8349590016231107
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25695,117,0.93 [0.61-1.42],0.7473023343482409
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25652,74,1.26 [0.78-2.04],0.3497776408383981
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25730,152,1.00 [0.69-1.43],0.980483399651608
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25646,68,1.14 [0.68-1.91],0.6310000748008386
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25909,331,0.65 [0.50-0.85],0.0014626112824455
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25328,293,1.08 [0.84-1.39],0.5512239044316614
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,25091,56,0.90 [0.49-1.64],0.7316265445648975
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,25091,56,1.56 [0.94-2.58],0.0833332633560174
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,25154,119,0.84 [0.55-1.29],0.423571300871899
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",25093,58,1.14 [0.65-1.99],0.6440836060869621
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,25101,66,0.87 [0.49-1.52],0.6165481300933214
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],25085,50,0.86 [0.45-1.65],0.6554429182119488
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25270,235,0.84 [0.62-1.13],0.2470095755476764
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,25088,53,0.74 [0.39-1.42],0.3647575193372269
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25091,56,0.52 [0.27-1.00],0.0486486067879904
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25149,114,0.68 [0.43-1.06],0.0904731778579932
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,25109,74,0.92 [0.54-1.55],0.7526865560205748
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25475,440,0.98 [0.79-1.21],0.8213036614068541
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25183,148,1.17 [0.83-1.65],0.3841234317038351
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25262,227,1.09 [0.82-1.46],0.5389702018908397
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27250,102,0.98 [0.63-1.52],0.9305793269437572
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27495,347,1.00 [0.79-1.27],0.9987632651864898
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,27206,58,1.11 [0.63-1.94],0.7185398007646474
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,27217,69,0.59 [0.33-1.07],0.0848522399987954
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27266,118,0.83 [0.54-1.27],0.3932807313641245
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24235,4498,0.88 [0.82-0.95],0.0012151785020036
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11644,421,0.89 [0.71-1.12],0.3238764092714637
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27090,212,1.28 [0.96-1.70],0.0946863953642412
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26934,56,1.42 [0.84-2.39],0.1894529083026489
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27247,44,0.82 [0.41-1.66],0.5847652660060554
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27253,50,1.86 [1.12-3.07],0.0157065252839066
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27256,53,1.21 [0.68-2.17],0.512298715470479
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28279,250,1.51 [1.18-1.92],0.0010312378645079
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28352,53,1.97 [1.26-3.09],0.0030449992412598
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28202,173,1.48 [1.10-1.98],0.0097431601372983
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,28128,99,1.69 [1.16-2.44],0.0057269695622253
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27107,898,0.91 [0.78-1.07],0.2554415168810888
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,26293,84,1.30 [0.82-2.04],0.2635576703795182
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26275,66,1.01 [0.59-1.74],0.9699998974668071
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26396,187,0.96 [0.69-1.33],0.8111850389284285
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26297,88,1.01 [0.63-1.63],0.9582767603908297
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26840,631,0.89 [0.74-1.07],0.2047957809392153
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11297,74,0.78 [0.45-1.34],0.3650379311698292
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11259,36,0.59 [0.25-1.37],0.2177917610717022
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,11262,39,0.86 [0.41-1.82],0.6903470977346435
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11316,93,1.47 [0.99-2.18],0.0579682432197486
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11290,67,1.12 [0.67-1.87],0.6618348957259467
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11327,104,0.93 [0.60-1.46],0.7641892542407278
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15651,254,0.84 [0.63-1.12],0.2361218027394843
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15470,73,0.93 [0.55-1.59],0.7989278932812166
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15487,90,0.79 [0.48-1.30],0.3546526170992309
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15452,55,0.85 [0.45-1.58],0.5999560178745622
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15615,399,0.76 [0.60-0.97],0.0248629851382987
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,15300,84,0.68 [0.40-1.14],0.1442085846965115
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15411,195,0.88 [0.63-1.22],0.434531545811994
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,14399,2833,0.88 [0.80-0.97],0.0088970345158555
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11870,304,0.80 [0.61-1.05],0.1033989890622726
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11659,93,0.66 [0.40-1.08],0.0981753421254685
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11685,119,0.60 [0.39-0.94],0.0243945211043603
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11879,313,0.53 [0.40-0.71],1.2478633844625805e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11876,310,0.74 [0.56-0.96],0.0262608765679241
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,12054,488,0.97 [0.79-1.19],0.7694778487351085
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11737,171,0.91 [0.64-1.30],0.6137224539754322
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11790,224,1.03 [0.76-1.38],0.8646840749033595
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11650,84,0.89 [0.54-1.47],0.6502432915841432
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11710,144,0.66 [0.45-0.99],0.0438316969259923
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15805,207,0.86 [0.62-1.19],0.3587164880306424
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15815,198,0.85 [0.61-1.18],0.3335333165168412
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15835,113,1.04 [0.68-1.58],0.8581284906093196
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15826,123,1.03 [0.69-1.53],0.9018574997335588
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11640,74,0.84 [0.49-1.45],0.5375111138035903
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11628,62,0.77 [0.43-1.41],0.4010385283024998
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11643,77,0.83 [0.49-1.41],0.4945743847077559
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,15727,387,1.00 [0.80-1.26],0.9917059349878004
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12735,1169,0.96 [0.84-1.10],0.5492533044392256
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,12365,799,0.94 [0.79-1.10],0.4281258836928167
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15813,160,1.02 [0.72-1.45],0.9195364528424724
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11928,362,0.77 [0.60-0.99],0.0382193476897407
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11853,287,0.82 [0.62-1.08],0.156493131498485
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11834,268,1.25 [0.96-1.62],0.0985025292911
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female infertility,11681,115,1.10 [0.73-1.66],0.6521386538418188
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11674,108,1.11 [0.72-1.69],0.6389809093015264
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15828,888,0.88 [0.75-1.05],0.1498874264625413
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15832,1214,0.92 [0.79-1.06],0.244363848391599
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15830,486,0.92 [0.75-1.14],0.4589482056900675
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15482,138,0.84 [0.56-1.24],0.3710776821702605
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15538,194,1.01 [0.73-1.40],0.9557505615606142
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15514,170,0.90 [0.64-1.28],0.5559418032135426
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15847,167,1.05 [0.74-1.49],0.7928599658610287
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15849,164,1.03 [0.72-1.47],0.8648228305155288
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15847,422,0.97 [0.78-1.22],0.8122966933019111
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15551,126,0.98 [0.66-1.46],0.9160894456442196
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15658,233,0.96 [0.71-1.30],0.7891434798746506
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,15089,149,0.68 [0.46-1.00],0.0487060910937451
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,15143,203,1.05 [0.77-1.45],0.7453052141636831
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,15193,253,0.92 [0.69-1.24],0.5961436966750917
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,15088,148,0.74 [0.50-1.10],0.1342598171521116
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,15080,140,0.61 [0.41-0.92],0.0176304964956067
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,15093,153,0.91 [0.63-1.32],0.6287351814369375
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14853,235,0.83 [0.61-1.13],0.2311687020784741
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],15062,444,0.90 [0.72-1.13],0.3597091003281776
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,15297,679,0.94 [0.78-1.14],0.5310648683568312
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15851,173,1.50 [1.09-2.06],0.0127746869253048
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,14377,132,1.56 [1.09-2.24],0.0140604424607694
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14721,103,1.17 [0.76-1.80],0.483254296316898
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15859,346,0.88 [0.69-1.13],0.3248332845833807
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15777,264,0.86 [0.64-1.14],0.2910601643366516
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15845,257,0.78 [0.58-1.04],0.0890933745997363
CLSTN2,Calsyntenin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15835,247,0.75 [0.56-1.02],0.0658398714624131
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28410,37,0.90 [0.43-1.89],0.7796059895224383
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26978,541,1.16 [0.97-1.40],0.1119451041431843
